Screener
XBI vs HEAL
State Street SPDR S&P Biotech ETF vs Global X HealthTech ETF
Key differences
- XBI costs 0.15% less per year.
- XBI is significantly larger than HEAL — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, XBI has delivered higher annualized returns.
- XBI has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| XBI | HEAL | |
|---|---|---|
| Annual cost (TER) | 0.35% | 0.50% |
| Fund size (AUM) | $8.3B | $25M |
| Since | 2006 | 2020 |
| Dividend yield | 0.34% | 0.38% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +66.6% | -20.2% |
| CAGR 3Y | +15.6% | -10.3% |
| CAGR 5Y | +0.9% | -14.0% |
| Sharpe 3Y | 0.54 | -0.46 |
| Volatility 1Y | 25.14% | 21.71% |
| Max drawdown | -63.89% | -65.76% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to XBI and HEAL
Explore further